BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PYVOBJECT//NONSGML Version 1//EN
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:20260429T152129Z - 4175@eupp247
DTSTART;TZID=Europe/Berlin:20200513T140000
DTEND;TZID=Europe/Berlin:20200513T140000
CREATED:20260429T152129Z
DESCRIPTION:<a href="https://academy.ant-neuro.com/event/identifying-strate
 gies-for-individualized-brain-stimulation-for-major-depressive-disorder-37
 /register">Identifying strategies for individualized brain stimulation for
  Major Depressive Disorder</a>\nThis webinar has ended. You can watch the 
 recorded session here. Welcome to ANT Neuro Educational Webinar Series! In
  this webinar\, we are happy to introduce TMS brain stimulation strategies
  for optimized MDD treatment. Standard 10 Hz Repetitive Transcranial Magne
 tic Stimulation (rTMS) is an effective treatment for Major Depressive Diso
 rder (MDD) with response rates between 30-40%. We show that rTMS-induced c
 hanges in functional brain connectivity can predict clinical outcome and t
 hat the proximity of the individual alpha frequency to the stimulation fre
 quency is associated with better clinical outcome. We will present a proce
 dure developed for the interrogation of frequencies between 3 – 17 Hz to
  identify the optimal stimulation frequency for MDD treatment. Individuali
 zed brain stimulation is highly promising for increasing clinical response
  rates. Biomarkers and early response predictors are critical in developin
 g the appropriate stimulation strategy. The presenter is Dr. Juliana Corli
 er who received her Ph.D in Cognitive Neuroscience from the Sorbonne Unive
 rsities in Paris\, France. Dr. Corlier has completed her postdoctoral trai
 ning at the UCLA Neuromodulation Division under the supervision of Dr. And
 rew Leuchter. In her current work as an assistant project scientist\, she 
 oversees projects that combine neuronavigated TMS\, simultaneous EEG recor
 dings and multimodal neuroimaging\, focusing on the development of biomark
 ers and individualized stimulation approaches to TMS treatment. This sessi
 on will be followed by a live demonstration of a navigated TMS setup by AN
 T Neuro application specialist/ product management team. Looking forward t
 o welcoming you to this webinar! Organization team ANT Neuro Education Dep
 artment [event ID: 4293] DISCLAIMER- Any medical information is provided a
 s a general information service only\, and is not intended as a substitute
  for [...]
DTSTAMP:20260429T152129Z
LOCATION:Online
SUMMARY:Identifying strategies for individualized brain stimulation for Maj
 or Depressive Disorder
X-ALT-DESC;FMTTYPE=text/html:<a href="https://academy.ant-neuro.com/event/i
 dentifying-strategies-for-individualized-brain-stimulation-for-major-depre
 ssive-disorder-37/register">Identifying strategies for individualized brai
 n stimulation for Major Depressive Disorder</a>\nThis webinar has ended. Y
 ou can watch the recorded session here. Welcome to ANT Neuro Educational W
 ebinar Series! In this webinar\, we are happy to introduce TMS brain stimu
 lation strategies for optimized MDD treatment. Standard 10 Hz Repetitive T
 ranscranial Magnetic Stimulation (rTMS) is an effective treatment for Majo
 r Depressive Disorder (MDD) with response rates between 30-40%. We show th
 at rTMS-induced changes in functional brain connectivity can predict clini
 cal outcome and that the proximity of the individual alpha frequency to th
 e stimulation frequency is associated with better clinical outcome. We wil
 l present a procedure developed for the interrogation of frequencies betwe
 en 3 – 17 Hz to identify the optimal stimulation frequency for MDD treat
 ment. Individualized brain stimulation is highly promising for increasing 
 clinical response rates. Biomarkers and early response predictors are crit
 ical in developing the appropriate stimulation strategy. The presenter is 
 Dr. Juliana Corlier who received her Ph.D in Cognitive Neuroscience from t
 he Sorbonne Universities in Paris\, France. Dr. Corlier has completed her 
 postdoctoral training at the UCLA Neuromodulation Division under the super
 vision of Dr. Andrew Leuchter. In her current work as an assistant project
  scientist\, she oversees projects that combine neuronavigated TMS\, simul
 taneous EEG recordings and multimodal neuroimaging\, focusing on the devel
 opment of biomarkers and individualized stimulation approaches to TMS trea
 tment. This session will be followed by a live demonstration of a navigate
 d TMS setup by ANT Neuro application specialist/ product management team. 
 Looking forward to welcoming you to this webinar! Organization team ANT Ne
 uro Education Department [event ID: 4293] DISCLAIMER- Any medical informat
 ion is provided as a general information service only\, and is not intende
 d as a substitute for [...]
END:VEVENT
END:VCALENDAR